Loyal Health (Loyal), a health tech company leveraging artificial intelligence to transform its operation through digital patient engagement, has secured $33.5M Series B financing to expand its customer base, accelerate product development, and support customer success.
Founded in 2015 by Chad Mallory, the company has received significant investments throughout its previous financing rounds. The latest round received contributions from existing investors such as Concord Health Partners and other strategic investors.
According to the company’s announcement, Saurabh Sinha, founder of Emids Technologies, has been appointed to head the Loyal Board of Directors, a position previously held by Chad Mallory before transitioning to the Senior Advisor role.
Mark Hipp has also joined the Loyal Board as part of the latest financing deal, bringing his extensive experience and expertise in advising and guiding technology-backed businesses.
Loyal Health’s Consumer Engagement Platform
The company’s consumer engagement platform aims to help healthcare organizations visualize their data in an easy-to-understand manner. This will facilitate decision-making across enterprises and make patient care journeys more efficient, consistent, and easily accessible.
The platform enables workflow efficiencies, equipping health systems with tools to deliver a seamless, connected digital experience. Additionally, it enables healthcare enterprises to gather consumer feedback and insights at every stage of the care journey.
Loyal Health’s latest funding reflects investors’ confidence in the company’s mission to improve healthcare system operations and consumer outcomes.
